Clinical Trial Update: NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II study evaluating natural killer (NK) cell infusion as remission-consolidation therapy for acute myeloid leukemia; the trial is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Natural killer cell infusion

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Acute Myeloid Leukaemia (AML) | Phase 2 | Status: NOT_YET_RECRUITING